tiprankstipranks
Trending News
More News >
ADC Therapeutics: Strong Financials and Promising Trials Support Buy Rating
PremiumRatingsADC Therapeutics: Strong Financials and Promising Trials Support Buy Rating
2M ago
ADC Therapeutics price target lowered to $7 from $10 at Guggenheim
Premium
The Fly
ADC Therapeutics price target lowered to $7 from $10 at Guggenheim
2M ago
ADC Therapeutics Earnings Call: Optimism Amid Challenges
Premium
Company Announcements
ADC Therapeutics Earnings Call: Optimism Amid Challenges
2M ago
ADC Therapeutics price target raised to $8 from $6 at Stephens
PremiumThe FlyADC Therapeutics price target raised to $8 from $6 at Stephens
3M ago
ADC Therapeutics Achieves Profitability with ZYNLONTA
Premium
Company Announcements
ADC Therapeutics Achieves Profitability with ZYNLONTA
4M ago
Closing Bell Movers: Inari adds 21% after confirmed Stryker buyout
Premium
The Fly
Closing Bell Movers: Inari adds 21% after confirmed Stryker buyout
5M ago
Molson Coors upgraded, Rivian downgraded: Wall Street’s top analyst calls
PremiumThe FlyMolson Coors upgraded, Rivian downgraded: Wall Street’s top analyst calls
6M ago
ADC Therapeutics Highlights Q3 Advances and Strategic Focus
Premium
Company Announcements
ADC Therapeutics Highlights Q3 Advances and Strategic Focus
7M ago
ADC Therapeutics initiated with an Overweight at Stephens
Premium
The Fly
ADC Therapeutics initiated with an Overweight at Stephens
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100